However, after the SELECT trial showed 20% MACE reduction, CMS issued guidance in March 2024 allowing Part D coverage of Wegovy specifically for cardiovascular risk reduction in patients with established CVD and a BMI of 27 or higher
However, a recent large meta-analysis showed no association between these three variants and low bone mineral density or fracture prevalence (102)
(According to Novo Nordisk, the drugs manufacturer, Ozempic can result in a slightly increased heart rate
The goal of these medications is to help you manage hunger and food noise, not eliminate it entirely
Post-Treatment Care and Results After receiving Tirzepatide treatment, follow these important aftercare tips to ensure the best possible outcomes: Keep track of how your body responds to the treatment and report any concerns to us
population aged 65 and over grew nearly five times faster than the total population over the 100 years from 1920 to 2020